Evidence map›Paper›PMID 40607211›Full record

ReviewFrontiers in cell and developmental biology2025

Large language models in the management of chronic ocular diseases: a scoping review.

Jiatong Zhang, Xiaoxi Song, Bocheng Tian, Mingke Tian, Zhichang Zhang, Jing Wang, Ting Fan

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiatong ZhangThe First Clinical Medical School, China Medical University, Shenyang, China.
Xiaoxi SongLiaoning Education Informatization Development Center, Liaoning Institute of Education, Shenyang, China.
Bocheng TianThe Second Clinical Medical School, China Medical University, Shenyang, China.
Mingke TianEmory College of Arts and Sciences, Emory University, Atlanta, United States.
Zhichang Zhang *School of Intelligent Medicine, China Medical University, Shenyang, China.
Jing Wang *The Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, China.
Ting Fan *School of Intelligent Medicine, China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large language models, a cutting-edge technology in artificial intelligence, are reshaping the new paradigm of chronic ocular diseases management. In this study, we comprehensively examined the current status and trends in the application of large language models in major blinding chronic ocular diseases such as glaucoma, cataract, and diabetic retinopathy through a systematic scoping review approach. We conducted this review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extended to characterize the application of large language models in the field of chronic ocular diseases. The study reveals that large language models demonstrate comparable efficacy to experts in disease screening, diagnostic decision-making, personalized precision treatment recommendation, and accessibility of healthcare resources by integrating multimodal clinical data. However, the application of the technology still faces a triple challenge: (1) the limitation of model generalization ability due to the multimodal nature of clinical data; (2) the ethical controversy caused by the insufficient interpretability of algorithms; and (3) the lack of a standardized validation framework. Future directions emphasize the need for specialized model training, multimodal algorithm optimization, the establishment of a multinational multicenter clinical validation platform, and the construction of an ethical framework for dynamic regulation. Large language models are expected to evolve from an assisted decision-making tool to a core component of precision medicine for chronic ocular diseases, and ultimately to achieve an ecosystem of energy-efficient full-cycle management of chronic ocular diseases.

Indexed as

chronic ocular diseasesclinical decision supportfull process managementlarge language modelsmultimodal data

Identifiers

PMID40607211
PMCPMC12213593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.